Ceramide-Protein Interactions Modulate Ceramide-Associated Lipotoxic Cardiomyopathy
Summary: Lipotoxic cardiomyopathy (LCM) is characterized by abnormal myocardial accumulation of lipids, including ceramide; however, the contribution of ceramide to the etiology of LCM is unclear. Here, we investigated the association of ceramide metabolism and ceramide-interacting proteins (CIPs) i...
Main Authors: | Stanley M. Walls, Anthony Cammarato, Dale A. Chatfield, Karen Ocorr, Greg L. Harris, Rolf Bodmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718302158 |
Similar Items
-
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy*s⃞
by: Tae-Sik Park, et al.
Published: (2008-10-01) -
Systemic and heart autonomous effects of sphingosine Δ4 desaturase deficiency in lipotoxic cardiac pathophysiology
by: Stanley M. Walls, et al.
Published: (2020-08-01) -
Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
by: Rebekah J. Nicholson, et al.
Published: (2021-01-01) -
Central Ceramide-Induced Hypothalamic Lipotoxicity and ER Stress Regulate Energy Balance
by: Cristina Contreras, et al.
Published: (2014-10-01) -
The two Cs: ceramide and cardiomyopathy1
by: Godfrey S. Getz
Published: (2008-10-01)